Clinical Trials Directory

Trials / Completed

CompletedNCT02480972

Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging

Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging (MRI)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess degree of hepatic fibrosis using multiparametric MRI for investigating difference between normal or early fibrosis and advanced fibrosis.

Detailed description

In patients with liver parenchymal disease or normal liver parenchyma who are scheduled to undergo either liver resection or liver biopsy are included. Referred patients undergo multiparametric MRI including perfusion, diffusion, elastography and fat quantification before surgery or biopsy. The pathophysiologic changes are evaluated using multiparametric MRI, and compared between normal/early fibrosis and advanced fibrosis.

Conditions

Interventions

TypeNameDescription
PROCEDUREmagnetic resonance imagingmultiparametric MRI as follows: 1. diffusion weighted imaging using multiple b-values 2. Fat quantification sequence 3. perfusion MRI using ECCM agent 4. MR elastography \------------------------------------ 5. routine MRI using hepatocyte specific agent (optional in patients with focal liver lesion)

Timeline

Start date
2015-06-23
Primary completion
2016-09-20
Completion
2020-08-28
First posted
2015-06-25
Last updated
2021-12-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02480972. Inclusion in this directory is not an endorsement.